Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

By S. Galli, M. Grimbaldeston, M. Tsai. Nature reviews. Immunology, 2008

775 citations recorded by the source corpus.

Subfields: Immunology, Physiology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/07a274dc55553a28cbed40baf7a8cb4b159f59c6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. A. Mantovani
2. A. Sica
3. P. Allavena
4. C. Garlanda
5. S. Galli
6. M. Tsai
7. F. Colotta
8. F. Balkwill

In Physiology

1. S. Galli
2. M. Tsai
3. A. Sica
4. A. Mantovani
5. C. Garlanda

In Rheumatology

1. S. Galli

Citations in the corpus

• The development of allergic inflammation (2008, background): “Some mast-cell products have the potential to recruit other immune cells either directly or indirectly (for example, TNF-α, LTB 4 , IL-8 (also known as CXCL8), CC-chemokine ligand 2 (CCL2) and many other chemokines), to activate innate immune cells (for example, TNF-α and IL-5), and to affect many a”
• Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. (2009, background): “However, also mast cells, neutrophils and even effectors of the adaptive immunity (especially in the form of antibodies) may activate inflammatory reactions that promote cancer progression [55,56].”